 |
|
Surtuin 1 as a potential prognostic biomarker in very elderly patients with colorectal cancer
Guk Jin Lee, Yun Hwa Jung, Tae-Jung Kim, Yosep Chong, Seo-Won Jeong, In Kyu Lee, In Sook Woo
Korean J Intern Med. 2021;36(Suppl 1):S235-S244. Published online 2020 Jul 2 DOI: https://doi.org/10.3904/kjim.2019.249
|
|
Citations to this article as recorded by
 Integrated analysis of non‑coding RNAs (HOTAIR and miR‑130a) and their cross‑talk with TGF‑β1, SIRT1 and E‑cadherin as potential biomarkers in colorectal cancer
Ghada Ayeldeen, Bahaa Badr, Olfat Shaker, Khaled Diab, Tarek Ahmed, Essam Hassan, Raghda Nagaty, Shaymaa Galal, Nabil Hasona
Oncology Letters.2025;[Epub] CrossRef Comprehensive analysis of the prognostic, immunological, and diagnostic roles of SIRT1 in pan-cancer and its validation in KIRC
Qi Liu, Songxian Sun, Chunxiang Zhou, Houxi Xu
Frontiers in Immunology.2025;[Epub] CrossRef SIRT1: a novel regulator in colorectal cancer
Weiwei Dong, Jinjing Lu, You Li, Juan Zeng, Xiaoyun Du, Ao Yu, Xuechan Zhao, Feng Chi, Zhuo Xi, Shuo Cao
Biomedicine & Pharmacotherapy.2024; 178: 117176. CrossRef Research Progress of Biological Function and Prognosis of Colorectal Cancer in Sirtuins Family
瑞阳 李
Journal of Clinical Personalized Medicine.2024; 03(04): 1805. CrossRef Decylubiquinone Inhibits Colorectal Cancer Growth Through Upregulating Sirtuin2
Jinlian Li, Shuting Zheng, Ting Cheng, Yuanyuan Li, Xiaobin Mai, Guangchun Jiang, Yongxia Yang, Qianqian Zhang, Jiangchao Li, Lingyun Zheng, Lijing Wang, Cuiling Qi
Frontiers in Pharmacology.2022;[Epub] CrossRef TSPYL2 Reduced Gefitinib Resistance and DNA Damage Repair Via Suppressing SIRT1-Mediated FOXO3 Deacetylation
Zimeng Liu, Chen Li, Changda Yu, Zhibing Chen, Chuanwen Zhao, Lin Ye
Future Medicinal Chemistry.2022; 14(6): 407. CrossRef
|